Which has preferable earnings & valuation, IGG or GNS?

IG Group has higher revenue and earnings than Genus. IG Group is trading at a lower price-to-earnings ratio than Genus, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio IG Group £949.10M 4.63 £533.35M £105.10 12.67 Genus £672M 2.17 £7.87M £71.00 30.87

Is IGG or GNS more profitable?

Genus has a net margin of 43.35% compared to IG Group's net margin of 30.26%. Genus' return on equity of 44.90% beat IG Group's return on equity. Company Net Margins Return on Equity Return on Assets IG Group 30.26% 19.99% 10.37% Genus 43.35% 44.90% 3.31%

Does the media refer more to IGG or GNS?

In the previous week, Genus had 12 more articles in the media than IG Group. MarketBeat recorded 13 mentions for Genus and 1 mentions for IG Group. Genus' average media sentiment score of 0.86 beat IG Group's score of 0.81 indicating that Genus is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IG Group 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Genus 5 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation & earnings, GNS or SMWH?

WH Smith has higher revenue and earnings than Genus. WH Smith is trading at a lower price-to-earnings ratio than Genus, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Genus £672M 2.17 £7.87M £71.00 30.87 WH Smith £1.59B 0.36 £63.01M -£96.70 N/A

Is GNS or SMWH more profitable?

Genus has a net margin of 43.35% compared to WH Smith's net margin of -9.48%. Genus' return on equity of 44.90% beat WH Smith's return on equity. Company Net Margins Return on Equity Return on Assets Genus 43.35% 44.90% 3.31% WH Smith -9.48% -90.46% 6.62%

Does the media refer more to GNS or SMWH?

In the previous week, Genus had 12 more articles in the media than WH Smith. MarketBeat recorded 13 mentions for Genus and 1 mentions for WH Smith. Genus' average media sentiment score of 0.86 beat WH Smith's score of -0.98 indicating that Genus is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Genus 5 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive WH Smith 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Negative

Which has preferable valuation and earnings, GNS or CPG?

Compass Group has higher revenue and earnings than Genus. Compass Group is trading at a lower price-to-earnings ratio than Genus, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Genus £672M 2.17 £7.87M £71.00 30.87 Compass Group £48.49B 0.01 £1.35B £118.70 0.26

Does the media prefer GNS or CPG?

In the previous week, Genus had 12 more articles in the media than Compass Group. MarketBeat recorded 13 mentions for Genus and 1 mentions for Compass Group. Genus' average media sentiment score of 0.86 beat Compass Group's score of 0.30 indicating that Genus is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Genus 5 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Compass Group 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend GNS or ALLG?

Genus currently has a consensus price target of GBX 3,216.67, indicating a potential upside of 46.75%. Given Genus' stronger consensus rating and higher possible upside, equities research analysts clearly believe Genus is more favorable than ALLG.L. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Genus 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 ALLG.L 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has better valuation & earnings, GNS or ALLG?

Genus has higher revenue and earnings than ALLG.L. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Genus £672M 2.17 £7.87M £71.00 30.87 ALLG.L N/A N/A N/A N/A N/A

Is GNS or ALLG more profitable?

Genus has a net margin of 43.35% compared to ALLG.L's net margin of 0.00%. Genus' return on equity of 44.90% beat ALLG.L's return on equity. Company Net Margins Return on Equity Return on Assets Genus 43.35% 44.90% 3.31% ALLG.L N/A N/A N/A

Does the media refer more to GNS or ALLG?

In the previous week, Genus had 12 more articles in the media than ALLG.L. MarketBeat recorded 13 mentions for Genus and 1 mentions for ALLG.L. Genus' average media sentiment score of 0.86 beat ALLG.L's score of 0.00 indicating that Genus is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Genus 5 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive ALLG.L 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger valuation and earnings, GNS or CVSG?

CVS Group has higher revenue and earnings than Genus. CVS Group is trading at a lower price-to-earnings ratio than Genus, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Genus £672M 2.17 £7.87M £71.00 30.87 CVS Group £692.80M 1.27 £20.68M £68.90 18.83

Is GNS or CVSG more profitable?

Genus has a net margin of 43.35% compared to CVS Group's net margin of 2.31%. Genus' return on equity of 44.90% beat CVS Group's return on equity. Company Net Margins Return on Equity Return on Assets Genus 43.35% 44.90% 3.31% CVS Group 2.31% 5.35% 5.03%

Does the media prefer GNS or CVSG?

In the previous week, Genus had 12 more articles in the media than CVS Group. MarketBeat recorded 13 mentions for Genus and 1 mentions for CVS Group. Genus' average media sentiment score of 0.86 beat CVS Group's score of 0.00 indicating that Genus is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Genus 5 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CVS Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Genus (GNS) Competitors

GBX 2,192 +32.00 (+1.48%)

As of 09/11/2026 12:29 PM Eastern

Compare

GNS vs. IGG, SMWH, CPG, ALLG, and CVSG

Should you buy Genus stock or one of its competitors? Genus's main competitors and comparable companies include IG Group (IGG), WH Smith (SMWH), Compass Group (CPG), ALLG.L (ALLG), and CVS Group (CVSG). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "diversified consumer services" industry.

How does Genus compare to IG Group?

IG Group (LON:IGG) and Genus (LON:GNS) are both consumer discretionary companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, media sentiment, earnings and profitability.

IG Group presently has a consensus price target of GBX 1,338, indicating a potential upside of 0.45%. Genus has a consensus price target of GBX 3,216.67, indicating a potential upside of 46.75%. Given Genus' higher probable upside, analysts clearly believe Genus is more favorable than IG Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IG Group	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00
Genus	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

74.0% of IG Group shares are owned by institutional investors. Comparatively, 54.8% of Genus shares are owned by institutional investors. 1.2% of IG Group shares are owned by company insiders. Comparatively, 0.7% of Genus shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Genus had 12 more articles in the media than IG Group. MarketBeat recorded 13 mentions for Genus and 1 mentions for IG Group. Genus' average media sentiment score of 0.86 beat IG Group's score of 0.81 indicating that Genus is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IG Group	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Genus	5 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

IG Group pays an annual dividend of GBX 46.50 per share and has a dividend yield of 3.5%. Genus pays an annual dividend of GBX 32 per share and has a dividend yield of 1.5%. IG Group pays out 44.2% of its earnings in the form of a dividend. Genus pays out 45.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. IG Group is clearly the better dividend stock, given its higher yield and lower payout ratio.

Genus has a net margin of 43.35% compared to IG Group's net margin of 30.26%. Genus' return on equity of 44.90% beat IG Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IG Group	30.26%	19.99%	10.37%
Genus	43.35%	44.90%	3.31%

IG Group has a beta of 0.498, indicating that its share price is 50% less volatile than the broader market. Comparatively, Genus has a beta of 0.902, indicating that its share price is 10% less volatile than the broader market.

IG Group has higher revenue and earnings than Genus. IG Group is trading at a lower price-to-earnings ratio than Genus, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IG Group	£949.10M	4.63	£533.35M	£105.10	12.67
Genus	£672M	2.17	£7.87M	£71.00	30.87

Summary

IG Group beats Genus on 10 of the 17 factors compared between the two stocks.

How does Genus compare to WH Smith?

Genus (LON:GNS) and WH Smith (LON:SMWH) are both small-cap consumer discretionary companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, analyst recommendations, risk, valuation, institutional ownership, media sentiment, profitability and dividends.

54.8% of Genus shares are held by institutional investors. Comparatively, 71.9% of WH Smith shares are held by institutional investors. 0.7% of Genus shares are held by insiders. Comparatively, 1.0% of WH Smith shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Genus has a net margin of 43.35% compared to WH Smith's net margin of -9.48%. Genus' return on equity of 44.90% beat WH Smith's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Genus	43.35%	44.90%	3.31%
WH Smith	-9.48%	-90.46%	6.62%

Genus currently has a consensus price target of GBX 3,216.67, suggesting a potential upside of 46.75%. WH Smith has a consensus price target of GBX 570, suggesting a potential upside of 52.32%. Given WH Smith's higher possible upside, analysts clearly believe WH Smith is more favorable than Genus.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Genus	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
WH Smith	0 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.43

Genus has a beta of 0.902, suggesting that its share price is 10% less volatile than the broader market. Comparatively, WH Smith has a beta of 0.929, suggesting that its share price is 7% less volatile than the broader market.

Genus pays an annual dividend of GBX 32 per share and has a dividend yield of 1.5%. WH Smith pays an annual dividend of GBX 17.30 per share and has a dividend yield of 4.6%. Genus pays out 45.1% of its earnings in the form of a dividend. WH Smith pays out -17.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. WH Smith is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, Genus had 12 more articles in the media than WH Smith. MarketBeat recorded 13 mentions for Genus and 1 mentions for WH Smith. Genus' average media sentiment score of 0.86 beat WH Smith's score of -0.98 indicating that Genus is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Genus	5 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
WH Smith	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Negative

WH Smith has higher revenue and earnings than Genus. WH Smith is trading at a lower price-to-earnings ratio than Genus, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Genus	£672M	2.17	£7.87M	£71.00	30.87
WH Smith	£1.59B	0.36	£63.01M	-£96.70	N/A

Summary

WH Smith beats Genus on 9 of the 17 factors compared between the two stocks.

How does Genus compare to Compass Group?

Genus (LON:GNS) and Compass Group (LON:CPG) are both small-cap consumer discretionary companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, institutional ownership, valuation, dividends and profitability.

In the previous week, Genus had 12 more articles in the media than Compass Group. MarketBeat recorded 13 mentions for Genus and 1 mentions for Compass Group. Genus' average media sentiment score of 0.86 beat Compass Group's score of 0.30 indicating that Genus is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Genus	5 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Compass Group	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Genus has a beta of 0.902, suggesting that its share price is 10% less volatile than the broader market. Comparatively, Compass Group has a beta of 0.653, suggesting that its share price is 35% less volatile than the broader market.

54.8% of Genus shares are owned by institutional investors. Comparatively, 68.2% of Compass Group shares are owned by institutional investors. 0.7% of Genus shares are owned by insiders. Comparatively, 0.5% of Compass Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Genus pays an annual dividend of GBX 32 per share and has a dividend yield of 1.5%. Compass Group pays an annual dividend of GBX 66.38 per share and has a dividend yield of 215.2%. Genus pays out 45.1% of its earnings in the form of a dividend. Compass Group pays out 55.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Genus presently has a consensus target price of GBX 3,216.67, suggesting a potential upside of 46.75%. Compass Group has a consensus target price of GBX 2,937.14, suggesting a potential upside of 9,420.72%. Given Compass Group's higher possible upside, analysts clearly believe Compass Group is more favorable than Genus.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Genus	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Compass Group	0 Sell rating(s)	0 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	3.00

Genus has a net margin of 43.35% compared to Compass Group's net margin of 4.20%. Genus' return on equity of 44.90% beat Compass Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Genus	43.35%	44.90%	3.31%
Compass Group	4.20%	26.12%	7.52%

Compass Group has higher revenue and earnings than Genus. Compass Group is trading at a lower price-to-earnings ratio than Genus, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Genus	£672M	2.17	£7.87M	£71.00	30.87
Compass Group	£48.49B	0.01	£1.35B	£118.70	0.26

Summary

Genus beats Compass Group on 9 of the 17 factors compared between the two stocks.

How does Genus compare to ALLG.L?

Genus (LON:GNS) and ALLG.L (LON:ALLG) are both consumer discretionary companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, valuation, analyst recommendations, profitability, media sentiment and earnings.

Genus has higher revenue and earnings than ALLG.L.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Genus	£672M	2.17	£7.87M	£71.00	30.87
ALLG.L	N/A	N/A	N/A	N/A	N/A

Genus has a net margin of 43.35% compared to ALLG.L's net margin of 0.00%. Genus' return on equity of 44.90% beat ALLG.L's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Genus	43.35%	44.90%	3.31%
ALLG.L	N/A	N/A	N/A

54.8% of Genus shares are owned by institutional investors. 0.7% of Genus shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Genus had 12 more articles in the media than ALLG.L. MarketBeat recorded 13 mentions for Genus and 1 mentions for ALLG.L. Genus' average media sentiment score of 0.86 beat ALLG.L's score of 0.00 indicating that Genus is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Genus	5 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
ALLG.L	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Genus currently has a consensus price target of GBX 3,216.67, indicating a potential upside of 46.75%. Given Genus' stronger consensus rating and higher possible upside, equities research analysts clearly believe Genus is more favorable than ALLG.L.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Genus	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
ALLG.L	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Genus beats ALLG.L on 11 of the 11 factors compared between the two stocks.

How does Genus compare to CVS Group?

Genus (LON:GNS) and CVS Group (LON:CVSG) are both small-cap consumer discretionary companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, earnings, analyst recommendations, valuation, media sentiment, profitability and risk.

54.8% of Genus shares are held by institutional investors. Comparatively, 48.5% of CVS Group shares are held by institutional investors. 0.7% of Genus shares are held by insiders. Comparatively, 1.5% of CVS Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Genus currently has a consensus price target of GBX 3,216.67, indicating a potential upside of 46.75%. CVS Group has a consensus price target of GBX 1,720, indicating a potential upside of 32.57%. Given Genus' stronger consensus rating and higher possible upside, equities research analysts plainly believe Genus is more favorable than CVS Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Genus	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
CVS Group	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.80

Genus has a net margin of 43.35% compared to CVS Group's net margin of 2.31%. Genus' return on equity of 44.90% beat CVS Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Genus	43.35%	44.90%	3.31%
CVS Group	2.31%	5.35%	5.03%

In the previous week, Genus had 12 more articles in the media than CVS Group. MarketBeat recorded 13 mentions for Genus and 1 mentions for CVS Group. Genus' average media sentiment score of 0.86 beat CVS Group's score of 0.00 indicating that Genus is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Genus	5 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CVS Group	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

CVS Group has higher revenue and earnings than Genus. CVS Group is trading at a lower price-to-earnings ratio than Genus, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Genus	£672M	2.17	£7.87M	£71.00	30.87
CVS Group	£692.80M	1.27	£20.68M	£68.90	18.83

Genus has a beta of 0.902, suggesting that its stock price is 10% less volatile than the broader market. Comparatively, CVS Group has a beta of 1.071, suggesting that its stock price is 7% more volatile than the broader market.

Genus pays an annual dividend of GBX 32 per share and has a dividend yield of 1.5%. CVS Group pays an annual dividend of GBX 8.50 per share and has a dividend yield of 0.7%. Genus pays out 45.1% of its earnings in the form of a dividend. CVS Group pays out 12.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Summary

Genus beats CVS Group on 11 of the 18 factors compared between the two stocks.

Get Genus News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

GNS vs. The Competition

Export

Metric	Genus	Diversified Consumer Services Industry	Consumer Discretionary Sector	LON Exchange
Market Cap	£1.46B	£4.28B	£12.71B	£2.51B
Dividend Yield	1.44%	2.87%	58.24%	6.23%
P/E Ratio	30.87	9.94	45.78	366.83
Price / Sales	2.17	35.65	93.61	83,599.68
Price / Cash	50.56	13.69	28.56	27.89
Price / Book	2.65	3.11	4.08	6.33
Net Income	£7.87M	£241.15M	£445.67M	£5.89B
7 Day Performance	-3.18%	-1.95%	-2.31%	-0.69%
1 Month Performance	-2.84%	-3.20%	-3.96%	0.18%
1 Year Performance	-16.18%	-6.70%	-6.12%	20.03%

Genus Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
GNS Genus	4.2394 of 5 stars	GBX 2,192 +1.5%	GBX 3,216.67 +46.7%	-18.6%	£1.46B	£672M	30.87	480	Trending News Earnings Report Analyst Forecast High Trading Volume
IGG IG Group	2.8764 of 5 stars	GBX 1,334 -0.4%	GBX 1,338 +0.3%	+15.0%	£4.40B	£949.10M	12.69	2,754
SMWH WH Smith	3.0757 of 5 stars	GBX 381.80 +1.9%	GBX 570 +49.3%	-45.7%	£574.61M	£1.59B	N/A	14,935	Gap Up
CPG Compass Group	3.7346 of 5 stars	GBX 30.61 +0.3%	GBX 2,932.50 +9,480.2%	-98.8%	£520.47M	£48.49B	0.26	550,000	News Coverage
ALLG ALLG.L	N/A	GBX 7.99 -0.4%	N/A	N/A	£0.00	N/A	N/A	140	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:GNS) was last updated on 9/12/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Genus (GNS) Competitors